ClinicalTrials.gg
RecruitingNCT02182921Updated Aug 28, 2024

Evaluation of Cataract Surgery Outcome

An observational study in Cataract and High Myopia, sponsored by Evidence Based Cataract Study Group. Recruiting at 1 site in China. Open to participants aged Up to 90 Years. Per ClinicalTrials.gov, last updated 2024-08-28.

Sponsored by Evidence Based Cataract Study Group · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
20,000
Ages
Up to 90 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 184 studies in Cataract with a site in China — 39 open to participants now, 49 under way, none of them phase 3. Cataract · China.

Planned enrollment
3rd of 73
20,000 · median 120
Started
2013
with 7 others
Observational
73 of 184
19 open now
Primary completion
2026-12
later than 32 of 48 live
Registered
21st of 184
by date

Among the 184 studies in Cataract with a site in China, this one is the 3rd largest by planned enrollment of the 73 observational ones that give a count, is one of 8 that started in 2013, is one of 73 observational ones, reaches primary completion later than 32 of the 48 other live ones, and was the 21st registered.

Cataract

1,633 studies on the registry are indexed under Cataract; 234 are open to participants now.

Browse Cataract studies →

Open to participants now

39 of the 184 studies in Cataract with a site in China are open now. Recruiting first, the newest first:

34 more — sign in →

All 39 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 143 Cataract studies recruiting now, 88 (62%) set no upper age limit and 8 (6%) stop at 75 or younger; 10 take children under 18; 15 take healthy volunteers.

This study: Up to 90 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 184 studies in Cataract with a site in China, or all of them as a file.
02

Study summary

The purpose of this study is to evaluate the visual outcome of the cataract surgery, including best uncorrected and corrected visual acuity, spherical equivalent, wavefront aberration and other measurements.

03

Conditions studied

  • Cataract
  • High Myopia

Browse trials for

04

Who can participate

Ages eligible
Up to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Medical centre: Eye and ENT Hospital of Fudan University

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Clinical diagnosis of cataract
  • Must be able to cooperate with the ophthalmic examination

Exclusion criteria

Exclusion Criteria:

  • Clinical diagnosis of mental illness
  • Mentally disabled
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
20,000 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Change from baseline in visual acuity at one month after cataract surgery

    Time frame: Follow-up until one month after surgery

  2. Change from baseline in spherical equivalent at one month after cataract surgery

    Time frame: Follow-up until one month after surgery

  3. Change from baseline in visual acuity at six months after cataract surgery

    Time frame: Follow-up until six months after surgery

  4. Change from baseline in spherical equivalent at six months after cataract surgery

    Time frame: Follow-up until six months after cataract surgery

Secondary outcomes

  1. Change from baseline in wavefront aberration at one month after cataract surgery

    Time frame: Follow-up until one month after surgery

  2. Change from baseline in contrast sensitivity at one month after cataract surgery

    Time frame: Follow-up until one month after surgery

  3. Change from baseline in intraocular light scattering at one month after cataract surgery

    Time frame: Follow-up until one month after surgery

  4. Change from baseline in wavefront aberration at six months after cataract surgery

    Time frame: Follow-up until six months after surgery

  5. Change from baseline in contrast sensitivity at six months after cataract surgery

    Time frame: Follow-up until six months after surgery

  6. Change from baseline in intraocular light scattering at six months after cataract surgery

    Time frame: Follow-up until six months after surgery

Other outcomes

  1. The difference between attempted and achieved refractive correction at one month after cataract surgery

    Time frame: Follow-up until one month after surgery

  2. The difference between attempted and achieved refractive correction at six months after cataract surgery

    Time frame: Follow-up until six months after surgery

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Yao Y, Meng J, He W, Zhang K, Wei L, Cheng K, Lu Y, Zhu X. Associations between anterior segment parameters and rotational stability of a plate-haptic toric intraocular lens. J Cataract Refract Surg. 2021 Nov 1;47(11):1436-1440. doi: 10.1097/j.jcrs.0000000000000653. PubMed 34675151 ↗
  • Lu Q, Wei L, He W, Zhang K, Wang J, Zhang Y, Rong X, Zhao Z, Cai L, He X, Wu J, Ding D, Lu Y, Zhu X. Lens Opacities Classification System III-based artificial intelligence program for automatic cataract grading. J Cataract Refract Surg. 2022 May 1;48(5):528-534. doi: 10.1097/j.jcrs.0000000000000790. PubMed 34433780 ↗
  • Zhu X, Lu Q, Yao Y, Xu X, Lu Y. Intraoperative Pain Sensation During Cataract Surgery: Why Does Timing Matter? Curr Eye Res. 2021 Jul;46(7):971-977. doi: 10.1080/02713683.2020.1857776. Epub 2020 Dec 15. PubMed 33249933 ↗
  • Lu Q, He W, Lu Y, Zhu X. Morphological features of anterior segment: factors influencing intraocular pressure after cataract surgery in nanophthalmos. Eye Vis (Lond). 2020 Sep 9;7:47. doi: 10.1186/s40662-020-00212-4. eCollection 2020. PubMed 32974413 ↗
  • Zhu X, Qi J, He W, Zhang S, Zhang K, Lu Q, Lu Y. Early transient intraocular pressure spike after cataract surgery in highly myopic cataract eyes and associated risk factors. Br J Ophthalmol. 2020 Aug;104(8):1137-1141. doi: 10.1136/bjophthalmol-2019-315117. Epub 2019 Nov 8. PubMed 31704699 ↗
  • Zhu X, He W, Zhang K, Lu Y. Factors influencing 1-year rotational stability of AcrySof Toric intraocular lenses. Br J Ophthalmol. 2016 Feb;100(2):263-8. doi: 10.1136/bjophthalmol-2015-306656. Epub 2015 Jun 18. PubMed 26089212 ↗
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Aug 2013, a primary completion of Dec 2026 and a completion of Dec 2030. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 24, 2014
First posted
Jul 8, 2014
Start
Aug 2013
Primary completionEst.
Dec 2026
CompletionEst.
Dec 2030
Last update
Aug 28, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 28, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02182921
Lead sponsor
Evidence Based Cataract Study Group
Responsible party
xiangjiazhu (MD, Evidence Based Cataract Study Group) — Principal investigator
First posted
Jul 8, 2014
Start date
Aug 2013
Primary completion
Dec 2026 (estimated)
Completion
Dec 2030 (estimated)
Last update
Aug 28, 2024

Study contacts

Yi Lu, MD
Contact
luyieent@163.com
(86)021-64377134
Yi Lu, MD
study chair · Eye and ENT Hospital of Fudan University
Xiangjia Zhu, MD
study director · Eye and ENT Hospital of Fudan University
Jin Yang, MD
study director · Eye and ENT Hospital of Fudan University
Keke Zhang, MD
principal investigator · Eye and ENT Hospital of Fudan University
Wenwen He, MD
principal investigator · Eye and ENT Hospital of Fudan University
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion